Fighting for the drug that pauses cystic fibrosis

Orkambi is a drug that targets a mutation that around 50% of people with cystic fibrosis in the UK have.

Source: BBC News | Health | UK Edition - May 11, 2019 Category: Consumer Health News Source Type: news